Anti-Infective and Anti-Inflammatory Mode of Action of Peptide 19-2.5
Open Access
- 2 February 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (3), 1465
- https://doi.org/10.3390/ijms22031465
Abstract
The polypeptide Pep19-2.5 (Aspidasept®) has been described to act efficiently against infection-inducing bacteria by binding and neutralizing their most potent toxins, i.e., lipopolysaccharides (LPS) and lipoproteins/peptides (LP), independent of the resistance status of the bacteria. The mode of action was described to consist of a primary Coulomb/polar interaction of the N-terminal region of Pep19-2.5 with the polar region of the toxins followed by a hydrophobic interaction of the C-terminal region of the peptide with the apolar moiety of the toxins. However, clinical development of Aspidasept as an anti-sepsis drug requires an in-depth characterization of the interaction of the peptide with the constituents of the human immune system and with other therapeutically relevant compounds such as antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs). In this contribution, relevant details of primary and secondary pharmacodynamics, off-site targets, and immunogenicity are presented, proving that Pep19-2.5 may be readily applied therapeutically against the deleterious effects of a severe bacterial infection.This publication has 25 references indexed in Scilit:
- LPS-neutralizing peptides reduce outer membrane vesicle-induced inflammatory responsesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2019
- Antibacterial action of synthetic antilipopolysaccharide peptides (SALP) involves neutralization of both membrane‐bound and free toxinsThe FEBS Journal, 2019
- Coupling killing to neutralization: combined therapy with ceftriaxone/Pep19-2.5 counteracts sepsis in rabbitsExperimental & Molecular Medicine, 2017
- Supramolecular structure of enterobacterial wild-type lipopolysaccharides (LPS), fractions thereof, and their neutralization by Pep19-2.5Journal of Structural Biology, 2016
- Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsisBiochimica et Biophysica Acta (BBA) - Biomembranes, 2016
- The Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human SepsisPLOS ONE, 2015
- Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptidesScientific Reports, 2015
- Preclinical Investigations Reveal the Broad-Spectrum Neutralizing Activity of Peptide Pep19-2.5 on Bacterial Pathogenicity FactorsAntimicrobial Agents and Chemotherapy, 2013
- Naturally Produced Outer Membrane Vesicles fromPseudomonas aeruginosaElicit a Potent Innate Immune Response via Combined Sensing of Both Lipopolysaccharide and Protein ComponentsInfection and Immunity, 2010
- Characterization of the lipid A component of genuine smooth‐form lipopolysaccharideJBIC Journal of Biological Inorganic Chemistry, 1989